Answers are grounded in this paper and cite their sources.
Shows IL-6 disrupts Th17/Treg balance in autoimmune prostatitis, indicating potential therapeutic targets.
Objective Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common urological condition in men. Although disruption of the Th17 (T helper 17)/Treg (regulatory T) balance has been implicated in its pathogenesis, the upstream drivers of this immune imbalance remain incompletely understood. This study investigated whether interleukin‐6 (IL‐6) is associated with altered Th17/Treg homeostasis and impaired Treg function in experimental autoimmune prostatitis (EAP). Methods An EAP model was generated in NOD mice through immunization with prostate antigen. Th17/Treg cell profiles were determined by flow cytometry, cytokine concentrations by enzyme‐linked immunosorbent assay (ELISA), and signal transducer and activator of transcription 5a (STAT5a) expression by western blotting and immunohistochemistry (IHC). In vivo IL‐6 inhibition was used to assess its effects on Th17/Treg balance and Treg suppressive function, whereas in vitro experiments examined the effects of IL‐6 on Treg function and naïve CD4 + T‐cell differentiation. Results Relative to control mice, EAP mice showed higher serum IL‐6 concentrations (5.28 ± 0.54 vs. 3.36 ± 0.46 pg/mL, p < 0.01), together with disturbed Th17/Treg homeostasis, as reflected by expansion of Th17 cells (1.72% ± 0.18% vs. 0.98% ± 0.08%, p < 0.001) and reduction of Treg cells (3.99% ± 0.97% vs. 5.46 % ± 0.53%, p < 0.05). Suppressive activity of Treg cells was also diminished (6.56% ± 0.80% vs. 12.41% ± 3.49%, p < 0.05). In vitro, IL‐6 shifted naïve CD4 + T‐cell differentiation toward the Th17 phenotype while limiting Treg generation and impairing Treg suppressive activity. Mechanistically, IL‐6 stimulation reduced STAT5a and p‐STAT5a expression in Treg cells. Pharmacological inhibition of IL‐6 partially restored Treg function and alleviated inflammatory pathology in EAP mice. Conclusion IL‐6 is linked to Th17/Treg imbalance and Treg dysfunction in EAP, possibly through inhibition of STAT5a signaling, and IL‐6‐related pathways may offer therapeutic value for CP/CPPS.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: